Atlas Trials

Evaluation the Treatment Outcome for RFA in Patients With BCLC Stage B HCC in Comparison With TACE

Clinical trial NCT03642561 · UNKNOWN

Trial details

NCT number
NCT03642561
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2019-09-03
Primary completion
2022-08-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.